The pandemic has created a lot of disruption in clinical trials, but not all of it has been negative. From accelerating the adoption of decentralized trials and speeding up the delivery of vaccines, to telemedicine and mHealth playing bigger roles in patients’ lives, opportunities have emerged to help us rediscover and recalibrate the way we perform clinical research. Many believe we can’t go back to the old way of doing things – so who’s leading the charge?
In this episode, we define what a movement is, learn how to be the “Dancing Man,” and discuss why the #NoGoingBack mission is so critical to preserving the progress we’ve made in clinical research. To talk about why this is so important, we've brought on two leaders of the #NoGoingBack movement, Maimah Karmo and Craig Lipset, to share what it means to them.
